Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J.C. Borel, B. Burel, R. Tamisier, S. Dias-Domingos, P. Levy, J.L. Pepin (La Tronche, Grenoble, Meylan, France). Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation. Eur Respir J 2012; 40: Suppl. 56, 1716

Member's Comments

No comment yet.

Related content which might interest you: CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Evaluation of cardiovascular risk after long-term c-PAP therapy in patients with obstructive sleep apnea. A 4-year follow-up Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters? Year: 2015 Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS? Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 CPAP therapy in OSA patients: The effects on healthcare use and medical costs related to cardio- and cerebrovascular diseases Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008 Analysis of patients with COPD requiring mechanical ventilation: characteristics, outcomes and risk factors for hospital mortality Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009 Short-term effects, long-term compliance and admissions in patients with obesity hypoventilation syndrome under noninvasive mechanical ventilation Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality Year: 2016 Can inflammatory markers predict mortality in COPD patients requiring mechanical ventilation? Source: Annual Congress 2010 - Intensive care unit outcome Year: 2010 Predictors of mortality in COVID-19 patients requiring CPAP Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients? Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 Long term non-invasive ventilation (LT-NIV) reduces mortality and the risk of hospital readmission in systemic COPD patients Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020